Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
24,798,327
-
Share change
-
+992,056
-
Total reported value
-
$2,528,981,361
-
Put/Call ratio
-
112%
-
Price per share
-
$102.06
-
Number of holders
-
255
-
Value change
-
+$83,729,768
-
Number of buys
-
132
-
Number of sells
-
121
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q3 2016
As of 30 Sep 2016,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
255 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,798,327 shares.
The largest 10 holders included
BlackRock Fund Advisors, VANGUARD GROUP INC, Knott David M, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, FMR LLC, VICTORY CAPITAL MANAGEMENT INC, WELLS FARGO & COMPANY/MN, STATE STREET CORP, OAK RIDGE INVESTMENTS LLC, and CARDINAL CAPITAL MANAGEMENT LLC /CT.
This page lists
255
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.